This study evaluates inclusion of National Comprehensive Cancer Network (NCCN) guideline recommended biomarkers for metastatic non–small cell lung cancer (NSCLC) in commercially available targeted next-generation sequencing (NGS) panels.
Elizabeth Brouwer, PhD
Advertisement
Articles by Elizabeth Brouwer, PhD
Advertisement
Latest Updated Articles
Do Targeted NGS Panels Include NSCLC Guideline-Recommended Biomarkers?February 12th 2026
Advertisement
Advertisement
Trending on AJMC
1
COVID-19 May Follow a Different Seasonal Pattern Than Influenza, RSV
2
House Passes Bill to Ease Medicare ACO Digital Quality Reporting Burden
3
Pediatric Cancer Carries Greater Financial Toxicity Than Adult Disease, Driving Calls for Systemic Change
4
Integrated VA Care Linked to Equitable Cancer Survival for Black Veterans
5